SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Guilford (GLFD) - Steadily Rising -- Ignore unavailable to you. Want to Upgrade?


To: Dr. Bob who wrote (148)11/5/1997 9:44:00 PM
From: BarryH  Respond to of 496
 
Has Alex Brown issued anything recently? THey got me interested in the stock orginally..

BarryH



To: Dr. Bob who wrote (148)11/5/1997 10:28:00 PM
From: tdinovo  Respond to of 496
 
Rob,

If logic were driving the stock, I would certainly agree. The problem is that some of current class of mutual fund managers pay no attention whatsoever to a company's fundamentals or potential. All they seem to concern themselves with is reported earnings per share. GLFD's nominal earning per share were down substantially, from $0.86 to 0.32 per share. Both current and last year's results were heavily influenced by one-time payments (Amgen this year and RPR last.) At this stage in its development, having ANY earnings per share is a notable accomplishments.

Nonetheless, the gurus of momentum posit that its one down quarter and out. And they are leaving! Generally, these are not times to be a hero. Let the volume slacken some and then scoop up some more shares. These geniuses are giving them to you at a bargain!

Ted